PCSK9-Mediated Inflammation in Foam Cell Formation and Exploring the Biologically Active Compounds Derived From Natural Resources.

IF 2.9 Q3 PHARMACOLOGY & PHARMACY
Advances in Pharmacological and Pharmaceutical Sciences Pub Date : 2026-08-29 eCollection Date: 2026-01-01 DOI:10.1155/adpp/3005975
Maharani Hestu Mukti Wisesa, Anisa Qisti Mathriul, Vicko Suswidiantoro, Meidi Utami Puteri, Mitsuyasu Kato, Muhd Hanis Md Idris, Fadlina Chany Saputri
{"title":"PCSK9-Mediated Inflammation in Foam Cell Formation and Exploring the Biologically Active Compounds Derived From Natural Resources.","authors":"Maharani Hestu Mukti Wisesa, Anisa Qisti Mathriul, Vicko Suswidiantoro, Meidi Utami Puteri, Mitsuyasu Kato, Muhd Hanis Md Idris, Fadlina Chany Saputri","doi":"10.1155/adpp/3005975","DOIUrl":null,"url":null,"abstract":"<p><p>Atherosclerosis develops as a persistent inflammatory condition that gradually alters the vascular structure and condition, in which the formation of macrophage-derived foam cells plays a central role in disease initiation and progression. Although proprotein convertase subtilisin/kexin type 9 (PCSK9) is widely recognised for its involvement in low-density lipoprotein receptor regulation and systemic lipid homeostasis, growing evidence indicates that PCSK9 also exerts a direct influence on macrophage inflammatory responses and intracellular lipid metabolism. Within atherosclerotic lesions, PCSK9 accelerates foam cell development by promoting oxidised low-density lipoprotein uptake, impairing cholesterol efflux through ABCA1 downregulation and activating key inflammatory pathways, particularly those mediated by TLR4/NF-κB and the NLRP3 inflammasome. This review emphasises recent findings that identify natural bioactive compounds as a novel and biologically relevant approach to counteracting PCSK9-driven inflammatory foam cell formation. Compounds such as salvianolic acid B, curcumin, quercetin, fisetin and myricetin display broad antiatherogenic properties by concurrently regulating macrophage polarisation, limiting scavenger receptor expression, suppressing inflammasome activation and modulating PCSK9 expression or function. In contrast to monoclonal PCSK9 inhibitors, which primarily address lipid lowering, these natural agents offer integrated anti-inflammatory and lipid-modulatory effects at the cellular level. Collectively, the evidence discussed in this review positions PCSK9 modulation by natural compounds as an emerging therapeutic concept that links lipid dysregulation with vascular inflammation. This multitarget strategy may complement current lipid-lowering therapies and support the development of more accessible and inflammation-focused interventions for atherosclerosis.</p>","PeriodicalId":7369,"journal":{"name":"Advances in Pharmacological and Pharmaceutical Sciences","volume":"2026 ","pages":"3005975"},"PeriodicalIF":2.9000,"publicationDate":"2026-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13525378/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Pharmacological and Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/adpp/3005975","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Atherosclerosis develops as a persistent inflammatory condition that gradually alters the vascular structure and condition, in which the formation of macrophage-derived foam cells plays a central role in disease initiation and progression. Although proprotein convertase subtilisin/kexin type 9 (PCSK9) is widely recognised for its involvement in low-density lipoprotein receptor regulation and systemic lipid homeostasis, growing evidence indicates that PCSK9 also exerts a direct influence on macrophage inflammatory responses and intracellular lipid metabolism. Within atherosclerotic lesions, PCSK9 accelerates foam cell development by promoting oxidised low-density lipoprotein uptake, impairing cholesterol efflux through ABCA1 downregulation and activating key inflammatory pathways, particularly those mediated by TLR4/NF-κB and the NLRP3 inflammasome. This review emphasises recent findings that identify natural bioactive compounds as a novel and biologically relevant approach to counteracting PCSK9-driven inflammatory foam cell formation. Compounds such as salvianolic acid B, curcumin, quercetin, fisetin and myricetin display broad antiatherogenic properties by concurrently regulating macrophage polarisation, limiting scavenger receptor expression, suppressing inflammasome activation and modulating PCSK9 expression or function. In contrast to monoclonal PCSK9 inhibitors, which primarily address lipid lowering, these natural agents offer integrated anti-inflammatory and lipid-modulatory effects at the cellular level. Collectively, the evidence discussed in this review positions PCSK9 modulation by natural compounds as an emerging therapeutic concept that links lipid dysregulation with vascular inflammation. This multitarget strategy may complement current lipid-lowering therapies and support the development of more accessible and inflammation-focused interventions for atherosclerosis.

泡沫细胞形成中pcsk9介导的炎症和探索来自自然资源的生物活性化合物。
动脉粥样硬化是一种逐渐改变血管结构和状况的持续性炎症,其中巨噬细胞衍生泡沫细胞的形成在疾病的发生和发展中起着核心作用。虽然蛋白转化酶枯草素/酮素9型(PCSK9)被广泛认为参与低密度脂蛋白受体调节和全身脂质稳态,但越来越多的证据表明PCSK9也直接影响巨噬细胞炎症反应和细胞内脂质代谢。在动脉粥样硬化病变中,PCSK9通过促进氧化的低密度脂蛋白摄取,通过ABCA1下调和激活关键炎症通路(特别是由TLR4/NF-κB和NLRP3炎症小体介导的炎症通路)来损害胆固醇外流,从而加速泡沫细胞的发育。这篇综述强调了最近发现的天然生物活性化合物作为一种新的和生物学相关的方法来对抗pcsk9驱动的炎症泡沫细胞形成。丹酚酸B、姜黄素、槲皮素、非瑟酮和杨梅素等化合物通过同时调节巨噬细胞极化、限制清扫剂受体表达、抑制炎性体激活和调节PCSK9表达或功能,显示出广泛的抗动脉粥样硬化特性。与主要用于降脂的单克隆PCSK9抑制剂相比,这些天然药物在细胞水平上具有综合的抗炎和脂质调节作用。总之,本综述中讨论的证据表明,天然化合物调节PCSK9是一种新兴的治疗概念,将脂质失调与血管炎症联系起来。这种多靶点策略可以补充目前的降脂疗法,并支持开发更容易获得的炎症聚焦动脉粥样硬化干预措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.30
自引率
3.60%
发文量
0
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书